PG
DIVO icon

Prostatis Group’s Amplify CWP Enhanced Dividend Income ETF DIVO Stock Holding History

Prostatis Group’s Portfolio DIVO Stock Details DIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Sell
457,179
-11,814
-3% -$541K 4.87% 2
2026
Q1 		$21M Buy
468,993
+10,765
+2% +$493K 5.38% 2
2025
Q4 		$20.4M Sell
458,228
-389
-0.1% -$17.5K 4.87% 2
2025
Q3 		$20.4M Buy
458,617
+16,655
+4% +$722K 5.12% 2
2025
Q2 		$18.8M Buy
441,962
+47,002
+12% +$1.91M 5.38% 2
2025
Q1 		$16.1M Buy
394,960
+61,767
+19% +$2.56M 5.08% 4
2024
Q4 		$13.5M Buy
333,193
+18,773
+6% +$779K 3.93% 5
2024
Q3 		$13M Buy
314,420
+18,972
+6% +$754K 4.24% 3
2024
Q2 		$11.4M Buy
295,448
+29,683
+11% +$1.14M 4.01% 4
2024
Q1 		$10.3M Buy
265,765
+28,916
+12% +$1.08M 3.91% 4
2023
Q4 		$8.66M Sell
236,849
-59,221
-20% -$2.08M 3.62% 5
2023
Q3 		$10.3M Sell
296,070
-9,394
-3% -$338K 5.06% 4
2023
Q2 		$11M Buy
305,464
+6,150
+2% +$218K 5.12% 4
2023
Q1 		$10.6M Sell
299,314
-7,939
-3% -$282K 5.6% 1
2022
Q4 		$11M Buy
307,253
+9,991
+3% +$352K 6.72% 2
2022
Q3 		$9.52M Buy
297,262
+49,430
+20% +$1.71M 10.97% 1
2022
Q2 		$8.31M Buy
247,832
+171,287
+224% +$6.1M 12.96% 2
2022
Q1 		$2.87M Buy
76,545
+28,869
+61% +$1.07M 2.3% 17
2021
Q4 		$1.82M Buy
47,676
+19,907
+72% +$737K 1.12% 29
2021
Q3 		$970K Buy
27,769
+17,726
+177% +$643K 0.58% 40
2021
Q2 		$360K Sell
10,043
-1,346
-12% -$47.9K 0.25% 73
2021
Q1 		$392K Buy
+11,389
New +$381K 0.31% 71

Other funds holding DIVO

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RPGK
Retirement Planning Group (Kansas) Leawood, Kansas $3.94B AUM 18.64% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Prostatis Group's DIVO Position: Q2 2026 in Review

Prostatis Group reduced its Amplify CWP Enhanced Dividend Income ETF (DIVO) stake by 2.5% in Q2 2026, selling an estimated $541K and leaving 457,179 shares worth $20.9M. The position accounts for 4.87% of the portfolio, ranked #2.

Prostatis Group first reported a position in DIVO in Q1 2021 and has held it in 22 quarters since. The position peaked at $21M in Q1 2026. 405 funds tracked by Wall St. Rank hold DIVO as of Q2 2026.

  • Prostatis Group held 457,179 shares of Amplify CWP Enhanced Dividend Income ETF worth $20.9M as of Q2 2026.
  • Prostatis Group sold 11,814 Amplify CWP Enhanced Dividend Income ETF shares in Q2 2026, an estimated $541K.
  • Amplify CWP Enhanced Dividend Income ETF made up 4.87% of Prostatis Group's portfolio in Q2 2026, its #2 holding.
  • Prostatis Group first reported a position in Amplify CWP Enhanced Dividend Income ETF in Q1 2021 and has held it in 22 quarters since.
  • Prostatis Group's Amplify CWP Enhanced Dividend Income ETF position peaked at $21M in Q1 2026.
  • 405 funds tracked by Wall St. Rank held Amplify CWP Enhanced Dividend Income ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.